BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37105317)

  • 41. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
    Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy.
    Longhi S; Bonfiglioli R; Obici L; Gagliardi C; Milandri A; Lorenzini M; Guidalotti PL; Merlini G; Rapezzi C
    Clin Nucl Med; 2015 May; 40(5):446-7. PubMed ID: 25742226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduction in
    Rettl R; Calabretta R; Duca F; Binder C; Kronberger C; Willixhofer R; Poledniczek M; Donà C; Nitsche C; Beitzke D; Loewe C; Auer-Grumbach M; Bonderman D; Kastl S; Hengstenberg C; Badr Eslam R; Kastner J; Bergler-Klein J; Hacker M; Kammerlander A
    Amyloid; 2024 Mar; 31(1):42-51. PubMed ID: 37599395
    [No Abstract]   [Full Text] [Related]  

  • 44. Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?
    Wollenweber T; Kretschmer-Chott E; Wurm R; Rasul S; Kulterer O; Rettl R; Duca F; Bonderman D; Sühs KW; Hacker M; Traub-Weidinger T
    J Nucl Cardiol; 2023 Feb; 30(1):357-367. PubMed ID: 35817943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy.
    Rettl R; Wollenweber T; Duca F; Binder C; Cherouny B; Dachs TM; Camuz Ligios L; Schrutka L; Dalos D; Beitzke D; Loewe C; Badr Eslam R; Kastner J; Hacker M; Bonderman D
    Eur Heart J Cardiovasc Imaging; 2023 Jul; 24(8):1019-1030. PubMed ID: 36881774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spleen visualization in both TTR and AL amyloidosis during
    Koutelou M; Tziomalos G; Chatzoglou V; Pappas N; Papanastasiou E; Chatzipavlidou V; Doumas A
    Hell J Nucl Med; 2023; 26(2):140-144. PubMed ID: 37527050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidental cardiac uptake of
    Salvalaggio A; Cipriani A; Righetto S; Artioli P; Sinigiani G; De Michieli L; Cason M; Pilichou K; Cecchin D; Briani C
    J Nucl Cardiol; 2022 Dec; 29(6):3419-3425. PubMed ID: 35437680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy.
    Rapezzi C; Quarta CC; Guidalotti PL; Longhi S; Pettinato C; Leone O; Ferlini A; Salvi F; Gallo P; Gagliardi C; Branzi A
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):470-8. PubMed ID: 21069320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantification of myocardial
    Manrique A; Dudoignon D; Brun S; N'Ganoa C; Cassol E; Legallois D; Lavie-Badie Y; Agostini D; Lairez O
    EJNMMI Res; 2019 Dec; 9(1):117. PubMed ID: 31873816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Noninvasive risk stratification of patients with transthyretin amyloidosis.
    Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
    JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.
    Papantoniou V; Valsamaki P; Kastritis S; Tsiouris S; Delichas Z; Papantoniou Y; Tsiouma M; Athanasoulis T; Fotopoulos A; Dimopoulos MA
    Hell J Nucl Med; 2015; 18 Suppl 1():42-50. PubMed ID: 26665211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease.
    Azevedo Coutinho MC; Cortez-Dias N; Cantinho G; Gonçalves S; Menezes MN; Guimarães T; Lima da Silva G; Francisco AR; Agostinho J; Santos L; Conceição I; Pinto FJ
    Amyloid; 2020 Sep; 27(3):174-183. PubMed ID: 32482106
    [No Abstract]   [Full Text] [Related]  

  • 53. Transthyretin Cardiac Amyloidosis Scintigraphy Using Planar D-SPECT on Dedicated Cardiac CZT Camera.
    Tshori S; Livschitz S; Volodarsky I; Goland S; Shimoni S; Fabrikant J; George J
    J Nucl Cardiol; 2022 Aug; 29(4):1995-2000. PubMed ID: 33977371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers.
    Piekarski E; Chequer R; Algalarrondo V; Eliahou L; Mahida B; Vigne J; Adams D; Slama MS; Le Guludec D; Rouzet F
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1108-1118. PubMed ID: 29511839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis.
    Quarta CC; Zheng J; Hutt D; Grigore SF; Manwani R; Sachchithanantham S; Mahmood SA; Whelan CJ; Fontana M; Martinez-Naharro A; Chacko L; Lachmann HJ; Gillmore JD; Rapezzi C; Hawkins PN; Wechalekar AD
    Eur Heart J Cardiovasc Imaging; 2021 Oct; 22(11):1304-1311. PubMed ID: 34254119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
    Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microcalcification and
    Mori A; Saito Y; Nakamura K; Iida T; Akagi S; Yoshida M; Taniyama M; Miyoshi T; Ito H
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Large Pleural Effusion: A Pitfall in the Quantitation of 99m Tc-PYP Imaging for ATTR Cardiac Amyloidosis.
    Khatri W; Polydefkis M; Vaishnav J; Saad E; Solnes LB; Rowe SP
    Clin Nucl Med; 2022 Sep; 47(9):e594-e595. PubMed ID: 35384890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
    Nagai T; Horinouchi H; Hashimoto K; Ichiji T; Yoshioka K; Hashimoto J; Ikari Y
    Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mitral Annular Calcification as a Potential False-Positive for Cardiac Amyloidosis in 99m Tc-DPD Scintigraphy Accurately Identified by SPECT/CT.
    Nunes ARP; Alves VM
    Clin Nucl Med; 2024 Apr; 49(4):e179-e181. PubMed ID: 38350093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.